RSS-Feed abonnieren
DOI: 10.1055/s-0029-1234119
© Georg Thieme Verlag KG Stuttgart · New York
Exercise Training Improved Insulin Sensitivity and Ovarian Morphology in Rats with Polycystic Ovary Syndrome
Publikationsverlauf
received 18.02.2009
accepted after second revision 15.07.2009
Publikationsdatum:
19. August 2009 (online)

Abstract
Hyperandrogenism and hyperinsulinemia are major clinical features in women with polycystic ovary syndrome (PCOS). We hypothesized that serum insulin levels reduced by exercise could relieve hyperandrogenism and ameliorate polycystic ovarian morphology. Wistar female rats with 21-day-old were randomly divided into three groups: PCOS exercise (P-Ex), PCOS sedentary (P-Sed), and control sedentary (C-Sed). The rats with PCOS were induced by injection with testosterone propionate continuously. The exercise program was to swim with 120 min/d for two weeks. Fasting blood glucose (FBG) and insulin (FINS), estrogen (E2), progesterone (P), and testosterone (T) in serum were determined by RIA, and ovarian morphology was evaluated by Image-Pro Plus 6.0. The levels of FINS, E2, and T in serum were significantly lower in P-Ex than in P-Sed. The ratios of FBG/FINS in P-Ex significantly increased in comparison with P-Sed. The levels of serum sex hormones in P-Ex were similar to C-Sed. There were no differences in blood glucose and serum progesterone among three groups. Ovarian morphology showed that the numbers of preantral follicles and atretic follicles significantly decreased, and the numbers of antral follicles and corpora lutea significantly increased in P-Ex compared with P-Sed. The changes of ovarian morphology in P-Ex were similar to C-Sed. These results demonstrated that short-term exercise training can improve insulin sensibility, decrease serum androgen levels, and recover normal ovarian morphology. The exercise training is the basic therapeutic means for PCOS.
Key words
exercise - polycystic ovary syndrome - insulin resistance - sex hormone - ovarian morphology
References
- 1
Norman RJ, Wu R, Stankiewicz MT.
4: Polycystic ovary syndrome.
Med J Aust.
2004;
180
132-137
Reference Ris Wihthout Link
- 2
Norman RJ, Dewailly D, Legro RS, Hickey TE.
Polycystic ovary syndrome.
Lancet.
2007;
370
685-697
Reference Ris Wihthout Link
- 3
Teede HJ, Hutchison SK, Zoungas S.
The management of insulin resistance in polycystic ovary syndrome.
Trends Endocrinol Metab.
2007;
18
273-279
Reference Ris Wihthout Link
- 4
Schuring AN, Schulte N, Sonntag B, Kiesel L.
Androgens and insulin – two key players in polycystic ovary syndrome. Recent concepts
in the pathophysiology and genetics of polycystic ovary syndrome.
Gynakol Geburtshilfliche Rundsch.
2008;
48
9-15
Reference Ris Wihthout Link
- 5
Moran L, Norman RJ.
Understanding and managing disturbances in insulin metabolism and body weight in women
with polycystic ovary syndrome.
Best Pract Res Clin Obstet Gynaecol.
2004;
18
719-736
Reference Ris Wihthout Link
- 6
Burghen GA, Givens JR, Kitabchi AE.
Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease.
J Clin Endocrinol Metab.
1980;
50
113-116
Reference Ris Wihthout Link
- 7
Guzick DS.
Polycystic ovary syndrome.
Obstet Gynecol.
2004;
103
181-193
Reference Ris Wihthout Link
- 8
Mlinar B, Marc J, Janez A, Pfeifer M.
Molecular mechanisms of insulin resistance and associated diseases.
Clin Chim Acta.
2007;
375
20-35
Reference Ris Wihthout Link
- 9
Diamanti-Kandarakis E, Papavassiliou AG.
Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
Trends Mol Med.
2006;
12
324-332
Reference Ris Wihthout Link
- 10
Galluzzo A, Amato MC, Giordano C.
Insulin resistance and polycystic ovary syndrome.
Nutr Metab Cardiovasc Dis.
2008;
18
511-518
Reference Ris Wihthout Link
- 11
Cataldo NA, Abbasi F, McLaughlin TL, Basina M, Fechner PY, Giudice LC, Reaven GM.
Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant
women with polycystic ovary syndrome.
Hum Reprod.
2006;
21
109-120
Reference Ris Wihthout Link
- 12
Khorram O, Helliwell JP, Katz S, Bonpane CM, Jaramillo L.
Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic
profiles in women with polycystic ovary syndrome.
Fertil Steril.
2006;
85
1448-1451
Reference Ris Wihthout Link
- 13
Guzick DS.
Ovulation induction management of PCOS.
Clin Obstet Gynecol.
2007;
50
255-267
Reference Ris Wihthout Link
- 14
Yan ZC, Liu DY, Zhang LL, Shen CY, Ma QL, Cao TB, Wang LJ, Nie H, Zidek W, Tepel M, Zhu ZM.
Exercise reduces adipose tissue via cannabinoid receptor type 1 which is regulated
by peroxisome proliferator-activated receptor-delta.
Biochem Biophys Res Commun.
2007;
354
427-433
Reference Ris Wihthout Link
- 15
Wang Y, Simar D, Fiatarone Singh MA.
Adaptations to exercise training within skeletal muscle in adults with type 2 diabetes
or impaired glucose tolerance: a systematic review.
Diabetes Metab Res Rev.
2009;
25
13-40
Reference Ris Wihthout Link
- 16
Kubota M, Koshinaka K, Kawata Y, Koike T, Oshida Y.
Effects of continuous low-carbohydrate diet after long-term exercise on GLUT-4 protein
content in rat skeletal muscle.
Horm Metab Res.
2008;
40
24-28
Reference Ris Wihthout Link
- 17
Jürimae J, Purge P, Jürimae T.
effect of prolonged training period on plasma adiponectin in elite male rowers.
Horm Metab Res.
2007;
39
519-523
Reference Ris Wihthout Link
- 18
Beloosesky R, Gold R, Almog B, Sasson R, Dantes A, Land-Bracha A, Hirsh L, Itskovitz-Eldor J, Lessing JB, Homburg R, Amsterdam A.
Induction of polycystic ovary by testosterone in immature female rats: Modulation
of apoptosis and attenuation of glucose/insulin ratio.
Int J Mol Med.
2004;
14
207-215
Reference Ris Wihthout Link
- 19
Morifuji M, Sanbongi C, Sugiura K.
Dietary soya protein intake and exercise training have an additive effect on skeletal
muscle fatty acid oxidation enzyme activities and mRNA levels in rats.
Br J Nutr.
2006;
96
469-475
Reference Ris Wihthout Link
- 20
Liu G, Shi F, Blas-Machado U, Duong Q, Davis VL, Foster WG, Hughes CL.
Ovarian effects of a high lactose diet in the female rat.
Reprod Nutr Dev.
2005;
45
185-192
Reference Ris Wihthout Link
- 21
Szukiewicz D, Uilenbroek JT.
Polycystic ovary syndrome – searching for an animal model.
J Med.
1998;
29
259-275
Reference Ris Wihthout Link
- 22
Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M, Stener-Victorin E.
A new rat model exhibiting both ovarian and metabolic characteristics of polycystic
ovary syndrome.
Endocrinology.
2007;
148
3781-3791
Reference Ris Wihthout Link
- 23
Holmang A, Larsson BM, Brzezinska Z, Bjorntorp P.
Effects of short-term testosterone exposure on insulin sensitivity of muscles in female
rats.
Am J Physiol.
1992;
262
E851-E855
Reference Ris Wihthout Link
- 24
Livingstone C, Collison M.
Sex steroids and insulin resistance.
Clin Sci (Lond).
2002;
102
151-166
Reference Ris Wihthout Link
- 25
Diamanti-Kandarakis E, Christakou C, Kandarakis H.
Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as
a risk factor for metabolic syndrome.
Minerva Endocrinol.
2007;
32
35-47
Reference Ris Wihthout Link
- 26
Iannello S, Camuto M, Cavaleri A, Milazzo P, Pisano MG, Bellomia D, Belfiore F.
Effects of short-term metformin treatment on insulin sensitivity of blood glucose
and free fatty acids.
Diabetes Obes Metab.
2004;
6
8-15
Reference Ris Wihthout Link
- 27
Sathyapalan T, Cho LW, Kilpatrick ES, Coady AM, Atkin SL.
Metformin maintains the weight loss and metabolic benefits following rimonabant treatment
in obese women with polycystic ovary syndrome (PCOS).
Clin Endocrinol (Oxf).
2009;
70
124-128
Reference Ris Wihthout Link
- 28
Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F.
Structured exercise training programme versus hypocaloric hyperproteic diet in obese
polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study.
Hum Reprod.
2008;
23
642-650
Reference Ris Wihthout Link
- 29
Allon MA, Leach RE, Dunbar J, Diamond MP.
Effects of chronic hyperandrogenism and/or administered central nervous system insulin
on ovarian manifestation and gonadotropin and steroid secretion.
Fertil Steril.
2005;
83
((Suppl 1))
1319-1326
Reference Ris Wihthout Link
- 30
Kuscu NK, Koyuncu F, Ozbilgin K, Inan S, Tuglu I, Karaer O.
Insulin: does it induce follicular arrest in the rat ovary?.
Gynecol Endocrinol.
2002;
16
361-364
Reference Ris Wihthout Link
- 31
Manneras L, Cajander S, Lonn M, Stener-Victorin E.
Acupuncture and Exercise Restore Adipose Tissue Expression of Sympathetic Markers
and Improve Ovarian Morphology in Rats with Dihydrotestosterone-Induced PCOS.
Am J Physiol Regul Integr Comp Physiol.
2009;
296
R1124-R1131
Reference Ris Wihthout Link
- 32
Manni L, Cajander S, Lundeberg T, Naylor AS, Aloe L, Holmang A, Jonsdottir IH, Stener-Victorin E.
Effect of exercise on ovarian morphology and expression of nerve growth factor and
alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic
ovaries.
J Neuroendocrinol.
2005;
17
846-858
Reference Ris Wihthout Link
- 33
Misugi T, Ozaki K, El Beltagy K, Tokuyama O, Honda K, Ishiko O.
Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced
PCOS rats.
Gynecol Obstet Invest.
2006;
61
208-215
Reference Ris Wihthout Link
- 34
Moraska A, Deak T, Spencer RL, Roth D, Fleshner M.
Treadmill running produces both positive and negative physiological adaptations in
Sprague-Dawley rats.
Am J Physiol Regul Integr Comp Physiol.
2000;
279
R1321-R1329
Reference Ris Wihthout Link
- 35
Vaanholt LM, Meerlo P, Garland, Visser GH, van Dijk G.
Plasma adiponectin is increased in mice selectively bred for high wheel-running activity,
but not by wheel running per sé.
Horm Metab Res.
2007;
39
377-383
Reference Ris Wihthout Link
- 36
Park E, Chan O, Li Q, Kiraly M, Matthews SG, Vranic M, Riddell MC.
Changes in basal hypothalamo-pituitary-adrenal activity during exercise training are
centrally mediated.
Am J Physiol Regul Integr Comp Physiol.
2005;
289
R1360-R1371
Reference Ris Wihthout Link
Correspondence
Z. JiangPhD, MD
Department of Rehabilitation Medicine
The First Affiliated Hospital of Nanjing Medical University
300 Guangzhou Road
210029 Nanjing
P. R. China
Telefon: +86/25/8331 87 52
Fax: +86/25/8331 87 52
eMail: jiangzh3721@yahoo.com.cn